A Clinical Trial to Assess a New Anti-Cancer Treatment (called DSB2455) Given On Its Own in Patients with Advanced Malignancies

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508805-26-00

Acronym

DSB2455-001

Enrollment

Registered

2024-09-23

Start date

2024-10-23

Completion date

Unknown

Last updated

2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer without active brain metastases, mCRPC without active brain metastases, ovarian cancer without active brain metastases, patients with active brain metastases, where the primary tumour has confirmed BRCA1/2 and/or HRR alterations

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

France, Spain

Outcome results